Market closed

Dyne Therapeutics/$DYN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Dyne Therapeutics

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

Ticker

$DYN
Trading on

Industry

Biotechnology

Employees

173

DYN Metrics

BasicAdvanced
$3.1B
Market cap
-
P/E ratio
-$3.51
EPS
1.10
Beta
-
Dividend rate
$3.1B
1.1
$47.45
$10.03
979K
17.022
16.728
2.841
3.523
-40.35%
-68.69%
4.33
4.33
-10.305
-3.06%
11.10%

What the Analysts think about DYN

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Dyne Therapeutics stock.

DYN Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DYN Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DYN

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Dyne Therapeutics stock?

Dyne Therapeutics (DYN) has a market cap of $3.1B as of November 22, 2024.

What is the P/E ratio for Dyne Therapeutics stock?

The price to earnings (P/E) ratio for Dyne Therapeutics (DYN) stock is 0 as of November 22, 2024.

Does Dyne Therapeutics stock pay dividends?

No, Dyne Therapeutics (DYN) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next Dyne Therapeutics dividend payment date?

Dyne Therapeutics (DYN) stock does not pay dividends to its shareholders.

What is the beta indicator for Dyne Therapeutics?

Dyne Therapeutics (DYN) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.